Literature DB >> 22366163

Sulfatases are determinants of alveolar formation.

Emilio Arteaga-Solis1, Carmine Settembre, Andrea Ballabio, Gerard Karsenty.   

Abstract

Alveolar formation or alveolarization is orchestrated by a finely regulated and complex interaction between growth factors and extracellular matrix proteins. The lung parenchyma contains various extracellular matrix proteins including proteoglycans, which are composed of glycosaminoglycans (GAGs) linked to a protein core. Although GAGs are known to regulate growth factor distribution and activity according to their degree of sulfation the role of sulfated GAG in the respiratory system is not well understood. The degree of sulfation of GAGs is regulated in part, by sulfatases that remove sulfate groups. In vertebrates, the enzyme Sulfatase-Modifying Factor 1 (Sumf1) activates all sulfatases. Here we utilized mice lacking Sumf1(-/-) to study the importance of proteoglycan desulfation in lung development. The Sumf1(-/-) mice have normal lungs up until the onset of alveolarization at post-natal day 5 (P5). We detected increased deposition of sulfated GAG throughout the lung parenchyma and a decrease in alveolar septa formation. Moreover, stereological analysis showed that the alveolar volume is 20% larger in Sumf1(-/-) as compared to wild type (WT) mice at P10 and P30. Additionally, pulmonary function test was consistent with increased alveolar volume. Genetic experiments demonstrate that in Sumf1(-/-) mice arrest of alveolarization is independent of fibroblast growth factor signaling. In turn, the Sumf1(-/-) mice have increased transforming growth factor β (TGFβ) signaling and in vivo injection of TGFβ neutralizing antibody leads to normalization of alveolarization. Thus, absence of sulfatase activity increases sulfated GAG deposition in the lungs causing deregulation of TGFβ signaling and arrest of alveolarization.
Copyright © 2012 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366163      PMCID: PMC3340524          DOI: 10.1016/j.matbio.2012.02.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  37 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Molecular diversity of heparan sulfate.

Authors:  J D Esko; U Lindahl
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Fgf18 is required for embryonic lung alveolar development.

Authors:  Hiroko Usui; Masaki Shibayama; Norihiko Ohbayashi; Morichika Konishi; Shinji Takada; Nobuyuki Itoh
Journal:  Biochem Biophys Res Commun       Date:  2004-09-24       Impact factor: 3.575

4.  A computer-controlled research ventilator for small animals: design and evaluation.

Authors:  T F Schuessler; J H Bates
Journal:  IEEE Trans Biomed Eng       Date:  1995-09       Impact factor: 4.538

5.  Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18.

Authors:  Zhonghao Liu; Jingsong Xu; Jennifer S Colvin; David M Ornitz
Journal:  Genes Dev       Date:  2002-04-01       Impact factor: 11.361

6.  Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome.

Authors:  Enid R Neptune; Pamela A Frischmeyer; Dan E Arking; Loretha Myers; Tracie E Bunton; Barbara Gayraud; Francesco Ramirez; Lynn Y Sakai; Harry C Dietz
Journal:  Nat Genet       Date:  2003-02-24       Impact factor: 38.330

Review 7.  The role of transforming growth factor beta in lung development and disease.

Authors:  Ulrike Bartram; Christian P Speer
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

8.  Combined forced oscillation and forced expiration measurements in mice for the assessment of airway hyperresponsiveness.

Authors:  Karim H Shalaby; Leslie G Gold; Thomas F Schuessler; James G Martin; Annette Robichaud
Journal:  Respir Res       Date:  2010-06-21

Review 9.  Transforming growth factor-beta: recent progress and new challenges.

Authors:  M B Sporn; A B Roberts
Journal:  J Cell Biol       Date:  1992-12       Impact factor: 10.539

10.  The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.

Authors:  Maria Pia Cosma; Stefano Pepe; Ida Annunziata; Robert F Newbold; Markus Grompe; Giancarlo Parenti; Andrea Ballabio
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

View more
  6 in total

Review 1.  Extracellular matrix in lung development, homeostasis and disease.

Authors:  Yong Zhou; Jeffrey C Horowitz; Alexandra Naba; Namasivayam Ambalavanan; Kamran Atabai; Jenna Balestrini; Peter B Bitterman; Richard A Corley; Bi-Sen Ding; Adam J Engler; Kirk C Hansen; James S Hagood; Farrah Kheradmand; Qing S Lin; Enid Neptune; Laura Niklason; Luis A Ortiz; William C Parks; Daniel J Tschumperlin; Eric S White; Harold A Chapman; Victor J Thannickal
Journal:  Matrix Biol       Date:  2018-03-08       Impact factor: 11.583

2.  Epithelial Deletion of Sulf2 Exacerbates Bleomycin-Induced Lung Injury, Inflammation, and Mortality.

Authors:  Xinping Yue
Journal:  Am J Respir Cell Mol Biol       Date:  2017-11       Impact factor: 6.914

3.  Single-nucleotide polymorphisms in the sulfatase-modifying factor 1 gene are associated with lung function and COPD.

Authors:  Linnea Jarenbäck; Sophia Frantz; Julie Weidner; Jaro Ankerst; Ulf Nihlén; Leif Bjermer; Per Wollmer; Ellen Tufvesson
Journal:  ERJ Open Res       Date:  2022-05-16

Review 4.  Implications for Extracellular Matrix Interactions With Human Lung Basal Stem Cells in Lung Development, Disease, and Airway Modeling.

Authors:  Shana M Busch; Zareeb Lorenzana; Amy L Ryan
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

5.  Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease.

Authors:  Julie Weidner; Linnea Jarenbäck; Kim de Jong; Judith M Vonk; Maarten van den Berge; Corry-Anke Brandsma; H Marike Boezen; Don Sin; Yohan Bossé; David Nickle; Jaro Ankerst; Leif Bjermer; Dirkje S Postma; Alen Faiz; Ellen Tufvesson
Journal:  Respir Res       Date:  2017-05-02

6.  Expression, activity and localization of lysosomal sulfatases in Chronic Obstructive Pulmonary Disease.

Authors:  Julie Weidner; Prajakta Jogdand; Linnea Jarenbäck; Ida Åberg; Dalja Helihel; Jaro Ankerst; Gunilla Westergren-Thorsson; Leif Bjermer; Jonas S Erjefält; Ellen Tufvesson
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.